Benzodiazepine Withdrawal Belongs in the Differential for Catatonia, but a Review Cannot Diagnose the Case

A plausible withdrawal mechanism needs an actual interruption history and a compatible clinical course.

What the supplied research shows

A clinical overview of catatonia discussed multiple psychiatric and medical associations, including reports following benzodiazepine withdrawal. It also described benzodiazepines as treatments for acute catatonic symptoms and considered proposed neurobiological mechanisms. The same drug class can therefore appear in different roles at different stages.

What it cannot establish

This was a review of heterogeneous evidence, including case-based observations. It cannot establish the incidence of withdrawal catatonia or prove that every episode after medication interruption was caused by withdrawal. Mechanistic hypotheses are not individualized diagnostic tests.

Forensic interpretation and case review

An expert should establish the prior regimen, adherence, interruption and symptom onset before labeling an event withdrawal-related. Distinguish resumption as treatment from exposure preceding the original syndrome. Consider competing neurological, metabolic and psychiatric explanations. The source supports inclusion of a mechanism in a differential assessment, while the final attribution must depend on the patient’s documented course rather than the drug class alone.

Source and related reading

Source: supplied full-text paper, PMC8628989. Findings are paraphrased; the forensic discussion is an interpretation of the evidence.

Related: Diazepam Was Part of Treatment After Antipsychotic-Associated Movement Symptoms During Alcohol Withdrawal.